Nuclear factor-κB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer

被引:116
|
作者
Fradet, V
Lessard, L
Bégin, LR
Karakiewicz, P
Masson, AMM
Saad, F
机构
[1] Univ Montreal, Ctr Hosp, Dept Chirurg Urol, Montreal, PQ H2L 4M1, Canada
[2] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ H2L 4M1, Canada
[3] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada
[4] Hop Sacre Coeur, Serv Anatomopathol, Montreal, PQ H4J 1C5, Canada
[5] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1158/1078-0432.CCR-04-0764
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Radical prostatectomy (RP) patients with positive surgical margins are at increased risk for recurrence, emphasizing the need for prognostic markers to stratify probable outcome for optimal patient management decisions. We tested the hypothesis that nuclear localization of nuclear factor (NF)-kappaB, a transcription factor involved in the regulation of cell growth, angiogenesis, invasion, and apoptosis, is associated with an increased risk of biochemical recurrence after RP. Experimental Design: Analyses addressed data from 42 patients (age range, 52-72 years; mean age, 63.7 years) who exhibited positive surgical margins after RP. Immunohistochemical analysis of NF-kappaB (p65) was performed on the positive margin tissue. A nuclear staining cutoff of >5% was considered positive. The relation between nuclear NF-kappaB expression and biochemical recurrence (prostate-specific antigen >0.3 ng/mL and rising) after RP was tested in univariate and multivariate Cox regression models. Results: Biochemical recurrence was recorded in 23 patients (54.8%; median follow-up, 3.2 years). Univariate Cox regression demonstrated a 4.9-fold (95% confidence interval, 1.5-16.7; P = 0.01) higher rate of recurrence in men with NF-kappaB > 5%. In the multivariate model, after controlling for primary (P = 0.004) and secondary (P = 0.7) Gleason patterns, lymph node (P = 0.06) and seminal vesicle invasion (P = 0.2), and preoperative prostate-specific antigen (P = 0.009), NF-kappaB > 5% was associated with a 6.2-fold higher risk of biochemical recurrence (95% confidence interval, 1.7-23.5; P = 0.007). Conclusions: In univariate and multivariate analysis, NF-kappaB nuclear expression was strongly predictive of biochemical recurrence in patients with positive surgical margins after RP. We propose that nuclear NF-kappaB may serve as a useful independent molecular marker for stratifying patients at risk for recurrence.
引用
收藏
页码:8460 / 8464
页数:5
相关论文
共 50 条
  • [1] Analysis of the Expression of Interleukins, Interferon β, and Nuclear Factor-κ B in Prostate Cancer and their Relationship With Biochemical Recurrence
    Eiro, Noemi
    Bermudez-Fernandez, Sandra
    Fernandez-Garcia, Belen
    Atienza, Sara
    Beridze, Nana
    Escaf, Safwan
    Vizoso, Francisco J.
    JOURNAL OF IMMUNOTHERAPY, 2014, 37 (07) : 366 - 373
  • [2] Is NF-κB predictive of biochemical recurrence in positive-margin prostate cancer?
    Carsten Stephan
    Glen Kristiansen
    Klaus Jung
    Nature Clinical Practice Urology, 2005, 2 : 134 - 135
  • [3] Is NF-κB predictive of biochemical recurrence in positive-margin prostate cancer?
    Stephan, C
    Kristiansen, G
    Jung, K
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (03): : 134 - 135
  • [4] NFKB expression predicts biochemical recurrence in patients with positive margin prostate cancer
    Fradet, V
    Lessard, L
    Mes-Masson, AM
    Begin, LR
    Perrotte, P
    Karakiewicz, PI
    Saad, F
    JOURNAL OF UROLOGY, 2004, 171 (04): : 288 - 288
  • [5] Nuclear localization of nuclear factor-κB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases
    Lessard, Laurent
    Karakievvicz, Pierre I.
    Bellon-Gagnon, Pascale
    Alam-Fahmy, Mona
    Ismail, Hazem A.
    Mes-Masson, Anne-Marie
    Saad, Fred
    CLINICAL CANCER RESEARCH, 2006, 12 (19) : 5741 - 5745
  • [6] Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse
    J Domingo-Domenech
    B Mellado
    B Ferrer
    D Truan
    J Codony-Servat
    S Sauleda
    J Alcover
    E Campo
    P Gascon
    A Rovira
    J S Ross
    P L Fernández
    J Albanell
    British Journal of Cancer, 2005, 93 : 1285 - 1294
  • [7] NUCLEAR FACTOR-κB CYTOPLASMATIC STAINING INTENSITY IS AN INDEPENDENT PREDICTOR OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER
    Isbarn, Hendrik
    Lessard, Laurent
    Karakiewicz, Pierre I.
    Schlomm, Thorsten
    Huland, Hartwig
    Sauter, Guido
    Koellermann, Jens
    Heinzer, Hans
    Graefen, Markus
    Saad, Fred
    JOURNAL OF UROLOGY, 2009, 181 (04): : 771 - 771
  • [8] Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse
    Domingo-Domenech, J
    Mellado, B
    Ferrer, B
    Truan, D
    Codony-Servat, J
    Sauleda, S
    Alcover, J
    Campo, E
    Gascon, P
    Rovira, A
    Ross, JS
    Fernández, PL
    Albanell, J
    BRITISH JOURNAL OF CANCER, 2005, 93 (11) : 1285 - 1294
  • [9] Nuclear factor-κB, cancer, and apoptosis
    Bours, V
    Bentires-Alj, M
    Hellin, AC
    Viatour, P
    Robe, P
    Delhalle, S
    Benoit, V
    Merville, MP
    BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) : 1085 - 1089
  • [10] Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas:: Correlation of nuclear factor-κB immunoreactivity with disease recurrence
    Ross, JS
    Kallakury, BVS
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Kaur, P
    Gray, K
    Stringer, B
    CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2466 - 2472